Sionna Therapeutics (NASDAQ:SION) Research Coverage Started at Stifel Nicolaus
Stifel Nicolaus initiated coverage on shares of Sionna Therapeutics (NASDAQ:SION – Free Report) in a research report sent to investors on Tuesday morning, MarketBeat reports. The firm issued a buy rating and a $32.00 target price on the stock. Separately, Guggenheim began coverage on shares of Sionna Therapeutics in a research report on Tuesday. They ...
Publicado el: 2025-03-07 07:18:44
Autor: MarketBeat News, Fuente: etfdailynews
Compartir: 
